Integrated Network Pharmacology Analysis and Experimental Validation to Elucidate the Mechanism of Acteoside in Treating Diabetic Kidney Disease

References

• Tuttle KR, Agarwal R, Alpers CE, et al. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022;102(2):248–260. doi:10.1016/j.kint.2022.05.012
   PubMed Web of Science ®Google Scholar
• Persson F, Rossing P. Diagnosis of diabetic kidney disease: state of the art and future perspective. Kidney Int. 2018;8(1):2–7. doi:10.1016/j.kisu.2017.10.003
   Web of Science ®Google Scholar
• Selby NM, Taal MW. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. 2020;22(1):3–15. doi:10.1111/dom.14007
   PubMedGoogle Scholar
• Samsu N, Bellini MI. Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment. Biomed Res Int. 2021;2021:1497449. doi:10.1155/2021/1497449
   PubMed Web of Science ®Google Scholar
• Valencia WM, Florez H. How to prevent the microvascular complications of type 2 diabetes beyond glucose control. Bmj. 2017;356:i6505. doi:10.1136/bmj.i6505
   PubMed Web of Science ®Google Scholar
• Yang C, Wang H, Zhao X, et al. CKD in China: evolving spectrum and public health implications. Am J Kidney Dis. 2020;76(2):258–264. doi:10.1053/j.ajkd.2019.05.032
   PubMed Web of Science ®Google Scholar
• Lu Z, Zhong Y, Liu W, Xiang L, Deng Y. The efficacy and mechanism of Chinese herbal medicine on diabetic kidney disease. J Diabetes Res. 2019;2019:2697672. doi:10.1155/2019/2697672
   PubMed Web of Science ®Google Scholar
• Lachowicz-Wiśniewska S, Pratap-Singh A, Kapusta I, et al. Flowers and leaves extracts of Stachys palustris l. exhibit stronger anti-proliferative, antioxidant, anti-diabetic, and anti-obesity potencies than stems and roots due to more phenolic compounds as revealed by UPLC-PDA-ESI-TQD-MS/MS. Pharmaceuticals. 2022;15(7):785. doi:10.3390/ph15070785
   Web of Science ®Google Scholar
• Wang Z, Xia Q, Liu X, et al. Phytochemistry, pharmacology, quality control and future research of Forsythia suspensa (Thunb.) Vahl: a review. J Ethnopharmacol. 2018;210:318–339. doi:10.1016/j.jep.2017.08.040
   PubMed Web of Science ®Google Scholar
• Zhao M, Qian D, Liu P, et al. Comparative pharmacokinetics of catalpol and acteoside in normal and chronic kidney disease rats after oral administration of rehmannia glutinosa extract. Biomed Chromatogr. 2015;29(12):1842–1848. doi:10.1002/bmc.3505
   PubMed Web of Science ®Google Scholar
• Chen X, Ge HZ, Lei SS, et al. Dendrobium officinalis six nostrum ameliorates urate under-excretion and protects renal dysfunction in lipid emulsion-induced hyperuricemic rats. Biomed Pharmacother. 2020;132:110765. doi:10.1016/j.biopha.2020.110765
   PubMed Web of Science ®Google Scholar
• Khan RA, Hossain R, Roy P, et al. Anticancer effects of acteoside: mechanistic insights and therapeutic status. Eur J Pharmacol. 2022;916:174699. doi:10.1016/j.ejphar.2021.174699
   PubMed Web of Science ®Google Scholar
• Khullar M, Sharma A, Wani A, et al. Acteoside ameliorates inflammatory responses through NFkB pathway in alcohol induced hepatic damage. Int Immunopharmacol Apr. 2019;69:109–117. doi:10.1016/j.intimp.2019.01.020
   PubMed Web of Science ®Google Scholar
• Lau CW, Chen ZY, Wong CM, et al. Attenuated endothelium-mediated relaxation by acteoside in rat aorta: role of endothelial [Ca2+]i and nitric oxide/cyclic GMP pathway. Life Sci. 2004;75(10):1149–1157. doi:10.1016/j.lfs.2003.12.031
   PubMed Web of Science ®Google Scholar
• Sheng GQ, Zhang JR, Pu XP, Ma J, Li CL. Protective effect of verbascoside on 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in PC12 cells. Eur J Pharmacol. 2002;451(2):119–124. doi:10.1016/j.biopha.2020.110765
   PubMed Web of Science ®Google Scholar
• Gao W, Zhou Y, Li C, et al. Studies on the metabolism and mechanism of acteoside in treating chronic glomerulonephritis. J Ethnopharmacol. 2023;302(Pt A):115866. doi:10.1016/j.jep.2022.115866
   PubMedGoogle Scholar
• Wang Q, Dai X, Xiang X, et al. A natural product of acteoside ameliorate kidney injury in diabetes db/db mice and HK-2 cells via regulating NADPH/oxidase-TGF-β/Smad signaling pathway. Phytother Res. 2021;35(9):5227–5240. doi:10.1002/ptr.7196
   PubMed Web of Science ®Google Scholar
• Li S, Zhang B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med. 2013;11(2):110–120. doi:10.3724/SP.J.1009.2013.00110
   PubMed Web of Science ®Google Scholar
• Barlow DJ, Buriani A, Ehrman T, Bosisio E, Eberini I, Hylands PJ. In-silico studies in Chinese herbal medicines’ research: evaluation of in-silico methodologies and phytochemical data sources, and a review of research to date. J Ethnopharmacol. 2012;140(3):526–534. doi:10.1016/j.jep.2012.01.041
   PubMed Web of Science ®Google Scholar
• Gao W, Gao S, Zhang Y, et al. Altered metabolic profiles and targets relevant to the protective effect of acteoside on diabetic nephropathy in db/db mice based on metabolomics and network pharmacology studies. J Ethnopharmacol. 2024;318(Pt B):117073. doi:10.1016/j.jep.2023.117073
   PubMedGoogle Scholar
• Xiao Y, Ren Q, Wu L. The pharmacokinetic property and pharmacological activity of acteoside: a review. Biomed Pharmacother. 2022;153:113296. doi:10.1016/j.biopha.2022.113296
   PubMed Web of Science ®Google Scholar
• Barutta F, Bellini S, Gruden G. Mechanisms of podocyte injury and implications for diabetic nephropathy. Clin Sci. 2022;136(7):493–520. doi:10.1042/cs20210625
   Web of Science ®Google Scholar
• Abeyrathna P, Su Y. The critical role of Akt in cardiovascular function. Vascul Pharmacol. 2015;74:38–48. doi:10.1016/j.vph.2015.05.008
   PubMed Web of Science ®Google Scholar
• Long HZ, Cheng Y, Zhou ZW, Luo HY, Wen DD, Gao LC. PI3K/AKT signal pathway: a target of natural products in the prevention and treatment of alzheimer’s disease and parkinson’s disease. Front Pharmacol. 2021;12:648636. doi:10.3389/fphar.2021.648636
   PubMed Web of Science ®Google Scholar
• Xie Y, Shi X, Sheng K, et al. PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (review). Mol Med Rep. 2019;19(2):783–791. doi:10.3892/mmr.2018.9713
   PubMed Web of Science ®Google Scholar
• Huang X, Liu G, Guo J, Su Z. The PI3K/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci. 2018;14(11):1483–1496. doi:10.7150/ijbs.27173
   PubMed Web of Science ®Google Scholar
• Xu W, Yang Z, Lu N. A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition. Cell Adh Migr. 2015;9(4):317–324. doi:10.1080/19336918.2015.1016686
   PubMed Web of Science ®Google Scholar
• Zhang X, Liang D, Chi ZH, et al. Effect of zinc on high glucose-induced epithelial-to-mesenchymal transition in renal tubular epithelial cells. Int J Mol Med. 2015;35(6):1747–1754. doi:10.3892/ijmm.2015.2170
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang Y, Luo M, et al. Elabela protects against podocyte injury in mice with streptozocin-induced diabetes by associating with the PI3K/Akt/mTOR pathway. Peptides. 2019;114:29–37. doi:10.1016/j.peptides.2019.04.005
   PubMed Web of Science ®Google Scholar
• Li Y, Zhao M, He D, et al. HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications. Lipids Health Dis. 2016;15:76. doi:10.1186/s12944-016-0246-z
   PubMed Web of Science ®Google Scholar
• Gao C, Fei X, Wang M, Chen Q, Zhao N. Cardamomin protects from diabetes-induced kidney damage through modulating PI3K/AKT and JAK/STAT signaling pathways in rats. Int Immunopharmacol. 2022;107:108610. doi:10.1016/j.intimp.2022.108610
   PubMed Web of Science ®Google Scholar
• Liu H, Chen W, Lu P, Ma Y, Liang X, Liu Y. Ginsenoside Rg1 attenuates the inflammation and oxidative stress induced by diabetic nephropathy through regulating the PI3K/AKT/FOXO3 pathway. Ann Transl Med. 2021;9(24):1789. doi:10.21037/atm-21-6234
   PubMed Web of Science ®Google Scholar
• Yang F, Qu Q, Zhao C, et al. Paecilomyces cicadae-fermented radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice. Biomed Pharmacother. 2020;129:110479. doi:10.1016/j.biopha.2020.110479
   PubMed Web of Science ®Google Scholar
• Ke G, Chen X, Liao R, et al. Receptor activator of NF-κB mediates podocyte injury in diabetic nephropathy. Kidney Int. 2021;100(2):377–390. doi:10.1016/j.kint.2021.04.036
   PubMed Web of Science ®Google Scholar
• Ma Z, Liu Y, Li C, Zhang Y, Lin N. Repurposing a clinically approved prescription Colquhounia root tablet to treat diabetic kidney disease via suppressing PI3K/AKT/NF-kB activation. Chin Med. 2022;17(1):2. doi:10.1186/s13020-021-00563-7
   PubMed Web of Science ®Google Scholar
• Wang Y, Jin M, Cheng CK, Li Q. Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives. Front Endocrinol. 2023;14:1238927. doi:10.3389/fendo.2023.1238927
   PubMed Web of Science ®Google Scholar
• Williams BM, Cliff CL, Lee K, Squires PE, Hills CE. The role of the nlrp3 inflammasome in mediating glomerular and tubular injury in diabetic nephropathy. Front Physiol. 2022;13:907504. doi:10.3389/fphys.2022.907504
   PubMed Web of Science ®Google Scholar